Chemical Synthesis Sample Clauses

Chemical Synthesis. Description Filename * * * * * * * * * * * * AMGEN consulting support AMGEN to provide consulting support (not to exceed * in the aggregate) in connection with the transfer of Licensed Know-How and Licensed Materials and the Exploitation of Products. The aggregate maximum * of consulting support shall be allocated across activities a, b, and c below.
Sample 1Sample 2
AutoNDA by SimpleDocs
Chemical Synthesis. Seller will provide Buyer one kilogram of the ------------------ active ingredient for TiterMax Gold and Seller's inventory of TiterMax Classic except 500 grams of TiterMax Classic (these items hereinafter, the "Reserve Inventory") which Seller will retain in its inventory. Seller shall provide Buyer with one (1) additional kilogram of the active ingredient for TiterMax Gold within two (2) months of Closing. Seller shall release the Reserve Inventory to Buyer at no additional cost when Buyer pays off the Secured Promissory Note attached hereto as Exhibit B. Future supplies (batches) shall be at the option of both parties. If Seller is unable or unwilling to synthesize additional materials, Seller shall provide Buyer with the know-how to develop the materials or have the materials developed by another party.
Sample 1
Chemical Synthesis. This is a license agreement under which you, the author, assign copyright in your article to OAE Publishing Inc. to allow us to publish your article, including abstract, tables, figures, data, and supplemental materials hosted by us, for the full period of copyright throughout the world, in all languages, in all forms and all media (whether known at this time or developed at any time in the future), subject to the terms and conditions below. Please read this agreement carefully, complete it, and then return a copy to us by e-mail: xxxxxxxxxxxxxxx@xxxxxxxxxxxxx.xxx. License OAE Publishing Inc. will apply the CC-BY License [Creative Commons Attribution 4.0 International License (xxxxx://xxxxxxxxxxxxxxx.xxx/licenses/by/4.0/)], which permits the author(s) to copy and redistribute the material in any medium or format, or to remix, transform, and build upon the material for any purpose, even commercially, provided that the user(s) appropriately acknowledge the original author(s) and the source. Assignment of Publishing Rights I hereby assign to OAE Publishing Inc. the following rights to the article, including any supplemental material, and any parts, extracts, or derivative works thereof: the right to carry out a peer-review of the submitted article; the right to make necessary and suitable editorial changes to the accepted article; the right to reproduce and distribute the published article in all forms and all media, including print-on-demand; the right to produce reprints, offprints, and special editions of the published article; the right to translate the published article into all other languages; the right to reproduce and distribute the published article by using such photomechanical or similar means as photocopy; the right to deposit the published article into any designated institutional repository; Rights of Authors Authors retain the following rights: copyright, and other proprietary rights relating to the article, such as patentrights; the right to use all or part of the article in their own works, including lectures and books; the right to reproduce the article for internal use, provided that the copies are not forsale; the right to present the article at a meeting/conference; the right to self-archive the article;
Sample 1
Chemical Synthesis. A joint Bayer/Xxxxx - Xxxxxx team will investigate the possibility of using Bayer's expertise in the chemical synthesis area to provide Schein with chemical drug ingredients. This could include, at Schein's request, future drugs to be launched by Schein, as well as supplying substances for Schein's current portfolio, all upon terms and conditions as may from time to time be mutually agreed to by Bayer/Miles and Schein. While it is the desire and expectation that cooperation as contemplated by these Heads of Agreements take place, all of this is subject to the independent decision making, operation, growth and functioning of each of the companies involved. These Heads of Agreement contemplate a dynamic and fluid relationship, and to avoid any misunderstanding, it is important that these and related points will become binding on the parties in respect of a particular project only upon execution of definitive, mutually satisfactory documentation. These Heads of Agreement have been executed as of this 30th day of September, 1994. XXXXX XX By: /s/ ----------------------- MILES INC. By: /s/ ----------------------- SCHEIN PHARMACEUTICAL, INC.
Sample 1

Related to Chemical Synthesis

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Insulin Insulin will be treated as a prescription drug subject to a separate copay for each type prescribed.

  • Chemical Substances Supplier warrants that: (i) each chemical substance contained in Products is on the inventory of chemical substances compiled and published by the Environmental Protection Agency pursuant to the Toxic Substances Control Act and (ii) all Material Safety Data Sheets required to be provided by Supplier for Products shall be provided to DXC prior to shipment of the Products and shall be complete and accurate.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Preceptor A per diem Registered Nurse 2 may serve as a preceptor after successfully completing a preceptor workshop or equivalent documented training and agreeing to and being appointed to be specifically responsible for planning, organizing, and evaluating the new skill development of one or more RNs as appropriate enrolled in a defined orientation program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the new or transferring employee. The per diem RN 2 preceptor is eligible to receive preceptor premium pay when actually engaged in preceptor role responsibilities with/on behalf of the orienting RN. A per diem RN 2 substituting for the original preceptor during a period of absence and who has been designated to carry out the preceptor's complete responsibility (including following and/or adjusting the plan to meet learning needs and providing oral and written evaluation input) will receive preceptor pay. A preceptor may be assigned to a student when it is determined by the Employer that the employee has completed the required preceptor training or has agreed to and been appointed a preceptor. The employee is specifically responsible for planning, organizing, and evaluating the new skill development of the student as appropriately enrolled in a defined program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the student.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Unbundled Channelization (Multiplexing) 5.7.1 To the extent NewPhone is purchasing DS1 or DS3 or STS-1 Dedicated Transport pursuant to this Agreement, Unbundled Channelization (UC) provides the optional multiplexing capability that will allow a DS1 (1.544 Mbps) or DS3 (44.736 Mbps) or STS-1 (51.84 Mbps) Network Elements to be multiplexed or channelized at a BellSouth central office. Channelization can be accomplished through the use of a multiplexer or a digital cross-connect system at the discretion of BellSouth. Once UC has been installed, NewPhone may request channel activation on a channelized facility and BellSouth shall connect the requested facilities via COCIs. The COCI must be compatible with the lower capacity facility and ordered with the lower capacity facility. This service is available as defined in NECA 4.

  • Reactivation To reactivate suspended Service, you must bring your account current through the month of reactivation by making payment in full of any outstanding balance, fees and other applicable charges. In addition, we may require a deposit before reactivating your Service. The amount of the deposit will not exceed one year of monthly fees. Any amounts deposited by you will appear on your statement as a credit, and service charges and other fees will be invoiced as described above. If you fail to pay any amount on a subsequent xxxx, the unpaid amount will be deducted each billing cycle from the credit amount. Credit amounts will not earn or accrue interest.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

Time is Money Join Law Insider Premium to draft better contracts faster.